Concepedia

Hiroto Ohguchi

HO

Statistics

Publications

34

Citations

2.8K

H-Index

25

Active since

1996

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Tohoku University

Massachusetts General Hospital

Kumamoto University

Hiroto Ohguchi is an author at Dana-Farber Cancer Institute specializing in oncology, multiple myeloma, and multiple myeloma therapy.

ORCID

Publications per year

1996–2024

34

Publications

34

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 435 citations · Full text

, , +9

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 305 citations · Full text

, , +17

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

J. Minami, Rikio Suzuki, Ralph Mazitschek et al. · Leukemia · 2013 · 160 citations

, , +16

Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination

Tadahito Yasuda, Mayu Koiwa, Atsuko Yonemura et al. · Cell Reports · 2021 · 157 citations · Full text

, , +17

Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma

Teru Hideshima, Jun Qi, Ronald M. Paranal et al. · Proceedings of the National Academy of Sciences · 2016 · 139 citations · Full text

, , +13

1–5 of 34